Stockscreener 앱 받기
0.6253
2.11%
-0.0135
시간 외 거래:
.71
0.0847
+13.55%
전일 마감가:
$0.6388
열려 있는:
$0.62
하루 거래량:
119.52K
Relative Volume:
0.37
시가총액:
$26.13M
수익:
-
순이익/손실:
$-74.56M
주가수익비율:
-0.3414
EPS:
-1.8316
순현금흐름:
$-60.27M
1주 성능:
-10.34%
1개월 성능:
+11.66%
6개월 성능:
+108.02%
1년 성능:
-36.84%
1일 변동 폭
$0.6057
$0.6404
1주일 범위
$0.6057
$0.708
52주 변동 폭
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
명칭
Rallybio Corp
전화
203- 859-3820
주소
234 CHURCH STREET, NEW HAVEN
RLYB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.6253 | 26.69M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-09 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-04-17 | 개시 | H.C. Wainwright | Buy |
| 2023-04-10 | 개시 | Wedbush | Outperform |
| 2022-12-09 | 개시 | JP Morgan | Overweight |
| 2022-02-22 | 개시 | JMP Securities | Mkt Outperform |
| 2021-08-23 | 개시 | Cowen | Outperform |
| 2021-08-23 | 개시 | Evercore ISI | Outperform |
| 2021-08-23 | 개시 | Jefferies | Buy |
모두보기
Rallybio Corp 주식(RLYB)의 최신 뉴스
How to build a custom watchlist for Rallybio CorporationJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Strategies to average down on Rallybio CorporationWeekly Market Summary & Real-Time Market Sentiment Reports - newser.com
Rallybio Swings To Profit And Gains Years Of Breathing Room - Finimize
How to monitor Rallybio Corporation with trend dashboardsJuly 2025 Chart Watch & Advanced Technical Analysis Signals - newser.com
Rallybio Corporation Reports Strong Q3 2025 Results - TipRanks
New Haven biotech Rallybio posts quarterly profit after asset sale - Hartford Business Journal
Biotech firm Rallybio's Q3 net income $16 mln, reverses prior loss - MarketScreener
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
Will Rallybio Corporation stock beat EPS estimates2025 Key Highlights & Safe Entry Zone Tips - newser.com
Will Rallybio Corporation continue its uptrendJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
Why retail investors favor Rallybio Corporation stockJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Is Rallybio Corporation trending in predictive chart models2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Published on: 2025-11-05 22:36:04 - newser.com
Published on: 2025-11-05 21:40:29 - newser.com
Published on: 2025-11-05 21:37:51 - newser.com
Why Rallybio Corporation stock remains on buy listsMarket Performance Recap & Weekly Return Optimization Alerts - newser.com
Rallybio (RLYB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Technical signs of recovery in Rallybio CorporationEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Can Rallybio Corporation stock hit record highs againWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
How Rallybio Corporation stock performs in rising dollar environmentJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Rallybio Corporation stock reversal real or fakeWall Street Watch & Capital Efficient Trade Techniques - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment - TipRanks
Rallybio Corp (RLYB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.44%
0.70%
자본화:
|
볼륨(24시간):